SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-011494
Filing Date
2022-11-16
Accepted
2022-11-16 16:41:21
Documents
1
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 BIRNDORF - CHANGES IN BENEFICIAL OWNERSHIP birndorf-form4_111422.html 4  
1 BIRNDORF - CHANGES IN BENEFICIAL OWNERSHIP birndorf-form4_111422.xml 4 6203
  Complete submission text file 0001387131-22-011494.txt   7745
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O NANOGEN INC 10398 PACIFIC CENTER COURT SAN DIEGO CA 92121
Business Address
BIRNDORF HOWARD C (Reporting) CIK: 0001078432 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 221395697